Package | hl7.fhir.uv.pddi |
Type | ValueSet |
Id | valueset-cyclosporine-exclude |
FHIR Version | R4 |
Source | http://hl7.org/fhir/uv/pddi/https://build.fhir.org/ig/HL7/PDDI-CDS/ValueSet-valueset-cyclosporine-exclude.html |
URL | http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude |
Version | 1.0.0-ballot |
Status | draft |
Date | 2018-07-02 |
Name | Valueset_cyclosporine_exclude |
Title | Exclude cyclosporine Medications Value Set |
Realm | uv |
Authority | hl7 |
Description | ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations. |
Purpose | To refine valueset for Digoxin + Cyclosporine PDDI-CDS |
Copyright | (copyright expectations unknown) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
rxnorm | RxNorm |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet valueset-cyclosporine-exclude
http://www.nlm.nih.gov/research/umls/rxnorm
Code | Display |
1093178 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune] |
402092 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] |
1093177 | Cyclosporine Ophthalmic Ointment [Optimmune] |
402330 | Cyclosporine Ophthalmic Suspension [Restasis] |
1093174 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment |
351291 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension |
1093173 | Cyclosporine Ophthalmic Ointment |
378766 | Cyclosporine Ophthalmic Suspension |
1156187 | Cyclosporine Ophthalmic Product |
1182342 | Optimmune Ophthalmic Product |
1182527 | Restasis Ophthalmic Product |
{ "resourceType": "ValueSet", "id": "valueset-cyclosporine-exclude", "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode": "cds" } ], "url": "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude", "version": "1.0.0-ballot", "name": "Valueset_cyclosporine_exclude", "title": "Exclude cyclosporine Medications Value Set", "status": "draft", "experimental": true, "date": "2018-07-02", "publisher": "HL7 Clinical Decision Support Workgroup", "contact": [ { "telecom": [ { "system": "url", "value": "http://hl7.org/Special/committees/dss" } ] } ], "description": "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.", "jurisdiction": [ { "coding": [ { "system": "http://unstats.un.org/unsd/methods/m49/m49.htm", "code": "001" } ] } ], "purpose": "To refine valueset for Digoxin + Cyclosporine PDDI-CDS", "copyright": "(copyright expectations unknown)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "1093178", "display": "Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]" }, { "code": "402092", "display": "Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]" }, { "code": "1093177", "display": "Cyclosporine Ophthalmic Ointment [Optimmune]" }, { "code": "402330", "display": "Cyclosporine Ophthalmic Suspension [Restasis]" }, { "code": "1093174", "display": "Cyclosporine 0.002 MG/MG Ophthalmic Ointment" }, { "code": "351291", "display": "Cyclosporine 0.5 MG/ML Ophthalmic Suspension" }, { "code": "1093173", "display": "Cyclosporine Ophthalmic Ointment" }, { "code": "378766", "display": "Cyclosporine Ophthalmic Suspension" }, { "code": "1156187", "display": "Cyclosporine Ophthalmic Product" }, { "code": "1182342", "display": "Optimmune Ophthalmic Product" }, { "code": "1182527", "display": "Restasis Ophthalmic Product" } ] } ] } }